Shingles (Herpes Zoster) Vaccination Information for Healthcare Providers

Two vaccines are licensed and recommended to prevent shingles in the U.S..  Zoster vaccine live (ZVL, Zostavax) has been in use since 2006. Recombinant zoster vaccine (RZV, Shingrix), has been in use since 2017 and is recommended by ACIP as the preferred shingles vaccine.

Shingrix Information for Healthcare Professionals

Two vaccines are licensed and recommended to prevent shingles in the U.S..  Zoster vaccine live (ZVL, Zostavax) has been in use since 2006. Recombinant zoster vaccine (RZV, Shingrix), has been in use since 2017 and is recommended by ACIP as the preferred shingles vaccine.

Page last reviewed: May 31, 2018